AFB (TB) – Antibiogram for MTb Complex – Kanamycin Drug by MGIT – Pure Growth of MTB Complex

This diagnostic lab test measures the drug susceptibility of the MTb complex specifically for kanamycin, an antibiotic used in TB treatment.

• This test helps determine if the MTb complex is resistant or sensitive to kanamycin. • To identify the most suitable drugs for treating TB caused by the MTb complex. • To guide clinicians in prescribing effective medications for patients with TB. • To monitor the development of drug resistance in TB strains. • To ensure appropriate treatment approaches for patients with drug-resistant TB.

This test may be recommended if you • Have been diagnosed with TB caused by the MTb complex. • Have not responded to initial TB treatment. • Are at high risk for drug-resistant TB due to previous treatment or exposure to resistant strains.

Abnormal results may suggest resistance to the antibiotic, requiring alternative medications for effective treatment.

Please reach out to your healthcare provider for any specific requirements.

• GeneXpert MTB/RIF Test: This molecular test helps detect TB and assess rifampicin resistance, another commonly used TB drug. • Chest X-ray: Imaging test used to evaluate lung involvement and assess the extent of TB infection.

Kanamycin Susceptibility Test for MTb Complex, Mycobacterial Growth Indicator Tube (MGIT) Kanamycin Drug Susceptibility Test

Tuberculosis (TB) is a contagious bacterial infection primarily affecting the lungs. It is caused by the Mycobacterium tuberculosis (MTb) complex. TB can spread through the air when an infected person coughs or sneezes. It is important to diagnose and treat TB promptly to prevent its spread and manage the infection effectively.